112 related articles for article (PubMed ID: 21492563)
1. Computational modeling of HHH therapy and impact of blood pressure and hematocrit.
Robinson JS; Walid MS; Hyun S; O'Connell R; Menard C; Bohleber B
World Neurosurg; 2010; 74(2-3):294-6. PubMed ID: 21492563
[TBL] [Abstract][Full Text] [Related]
2. Haemodynamic augmentation in the treatment of vasospasm in aneurysmal subarachnoid hemorrhage.
Gura M; Elmaci I; Cerci A; Sagiroglu E; Coskun KK
Turk Neurosurg; 2012; 22(4):435-40. PubMed ID: 22843460
[TBL] [Abstract][Full Text] [Related]
3. Effects of hypervolemia and hypertension on regional cerebral blood flow, intracranial pressure, and brain tissue oxygenation after subarachnoid hemorrhage.
Muench E; Horn P; Bauhuf C; Roth H; Philipps M; Hermann P; Quintel M; Schmiedek P; Vajkoczy P
Crit Care Med; 2007 Aug; 35(8):1844-51; quiz 1852. PubMed ID: 17581487
[TBL] [Abstract][Full Text] [Related]
4. A computational simulation of the effect of hemodilution on oxygen transport in middle cerebral artery vasospasm.
Chittiboina P; Guthikonda B; Wollblad C; Conrad SA
J Cereb Blood Flow Metab; 2011 Nov; 31(11):2209-17. PubMed ID: 21629259
[TBL] [Abstract][Full Text] [Related]
5. Effects of iso- and hypervolemic hemodilution on regional cerebral blood flow and oxygen delivery for patients with vasospasm after aneurysmal subarachnoid hemorrhage.
Ekelund A; Reinstrup P; Ryding E; Andersson AM; Molund T; Kristiansson KA; Romner B; Brandt L; Säveland H
Acta Neurochir (Wien); 2002 Jul; 144(7):703-12; discussion 712-3. PubMed ID: 12181704
[TBL] [Abstract][Full Text] [Related]
6. Sphenopalatine ganglion stimulation for vasospasm after experimental subarachnoid hemorrhage.
Takahashi M; Zhang ZD; Macdonald RL
J Neurosurg; 2011 Apr; 114(4):1104-9. PubMed ID: 20597600
[TBL] [Abstract][Full Text] [Related]
7. Flow Behavior and Distribution of Embolus-Model Particles at the Terminal Bifurcation of the Human Internal Carotid Artery.
Kobayashi N; Karino T
World Neurosurg; 2016 Jun; 90():469-477. PubMed ID: 26987631
[TBL] [Abstract][Full Text] [Related]
8. Role of transcranial Doppler in optimizing treatment of cerebral vasospasm in subarachnoid hemorrhage.
Darwish RS; Ahn E; Amiridze NS
J Intensive Care Med; 2008; 23(4):263-7. PubMed ID: 18480082
[TBL] [Abstract][Full Text] [Related]
9. Molsidomine for the prevention of vasospasm-related delayed ischemic neurological deficits and delayed brain infarction and the improvement of clinical outcome after subarachnoid hemorrhage: a single-center clinical observational study.
Ehlert A; Schmidt C; Wölfer J; Manthei G; Jacobs AH; Brüning R; Heindel W; Ringelstein EB; Stummer W; Pluta RM; Hesselmann V
J Neurosurg; 2016 Jan; 124(1):51-8. PubMed ID: 26162034
[TBL] [Abstract][Full Text] [Related]
10. Effect of intracarotid nitric oxide on primate cerebral vasospasm after subarachnoid hemorrhage.
Afshar JK; Pluta RM; Boock RJ; Thompson BG; Oldfield EH
J Neurosurg; 1995 Jul; 83(1):118-22. PubMed ID: 7782826
[TBL] [Abstract][Full Text] [Related]
11. New concepts regarding cerebral vasospasm: glial-centric mechanisms.
Mutch WA
Can J Anaesth; 2010 May; 57(5):479-89. PubMed ID: 20131107
[TBL] [Abstract][Full Text] [Related]
12. The present role of "triple-H" therapy in the management of cerebral vasospasm.
Findlay JM
World Neurosurg; 2010; 74(2-3):244-6. PubMed ID: 21492545
[No Abstract] [Full Text] [Related]
13. Modulation of cerebral blood flow with transcutaneous electrical neurostimulation (TENS) in patients with cerebral vasospasm after subarachnoid hemorrhage.
ter Laan M; van Dijk JM; Stewart R; Staal MJ; Elting JW
Neuromodulation; 2014 Jul; 17(5):431-6; discussion 436-7. PubMed ID: 24725157
[TBL] [Abstract][Full Text] [Related]
14. Increases in cardiac output can reverse flow deficits from vasospasm independent of blood pressure: a study using xenon computed tomographic measurement of cerebral blood flow.
Joseph M; Ziadi S; Nates J; Dannenbaum M; Malkoff M
Neurosurgery; 2003 Nov; 53(5):1044-51; discussion 1051-2. PubMed ID: 14580270
[TBL] [Abstract][Full Text] [Related]
15. Hemodynamic consequences of cerebral vasospasm on perforating arteries: a phantom model study.
Soustiel JF; Levy E; Bibi R; Lukaschuk S; Manor D
Stroke; 2001 Mar; 32(3):629-35. PubMed ID: 11239178
[TBL] [Abstract][Full Text] [Related]
16. Relative importance of hypertension compared with hypervolemia for increasing cerebral oxygenation in patients with cerebral vasospasm after subarachnoid hemorrhage.
Raabe A; Beck J; Keller M; Vatter H; Zimmermann M; Seifert V
J Neurosurg; 2005 Dec; 103(6):974-81. PubMed ID: 16381183
[TBL] [Abstract][Full Text] [Related]
17. Which H is the most important in triple-H therapy for cerebral vasospasm?
Treggiari MM; Deem S
Curr Opin Crit Care; 2009 Apr; 15(2):83-6. PubMed ID: 19276798
[TBL] [Abstract][Full Text] [Related]
18. Detecting and treating microvascular ischemia after subarachnoid hemorrhage.
Sakowitz OW; Unterberg AW
Curr Opin Crit Care; 2006 Apr; 12(2):103-11. PubMed ID: 16543784
[TBL] [Abstract][Full Text] [Related]
19. Vasospasm probability index: a combination of transcranial doppler velocities, cerebral blood flow, and clinical risk factors to predict cerebral vasospasm after aneurysmal subarachnoid hemorrhage.
Gonzalez NR; Boscardin WJ; Glenn T; Vinuela F; Martin NA
J Neurosurg; 2007 Dec; 107(6):1101-12. PubMed ID: 18077946
[TBL] [Abstract][Full Text] [Related]
20. "Triple-H" therapy for cerebral vasospasm following subarachnoid hemorrhage.
Lee KH; Lukovits T; Friedman JA
Neurocrit Care; 2006; 4(1):68-76. PubMed ID: 16498198
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
